HYDROPEN PENICILLIN/DIHYDROSTREPTOMYCIN INJECTION

Main information

  • Trade name:
  • HYDROPEN PENICILLIN/DIHYDROSTREPTOMYCIN INJECTION
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • HYDROPEN PENICILLIN/DIHYDROSTREPTOMYCIN INJECTION
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CAT | CATTLE | DOG | PIGS | SHEEP | BEEF | BITCH | BOAR | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF |
  • Therapeutic area:
  • ANTIBIOTIC & RELATED
  • Therapeutic indications:
  • NOT APPLICABLE (VET)

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 36022
  • Last update:
  • 09-08-2016

There are no safety alerts related to this product.

21-9-2018

Scientific guideline:  Reflection paper on the use of aminopenicillins and their beta-lactamase inhibitor combinations in animals in the European Union: development of resistance and impact on human and animal health, draft: consultation open

Scientific guideline: Reflection paper on the use of aminopenicillins and their beta-lactamase inhibitor combinations in animals in the European Union: development of resistance and impact on human and animal health, draft: consultation open

The objective of this document is to review available information on the use of aminopenicillins and their beta-lactamase inhibitor combinations in veterinary medicines in the EU, their effect on the emergence of antimicrobial resistance (AMR) and the potential impact of resistance on human and animal health. The document provides information for the risk profiling, as recommended by the Antimicrobial Advice ad hoc Expert Group (AMEG) of the EMA.

Europe - EMA - European Medicines Agency